Sana Biotechnology to Present at September 2026 Investor Conferences
Sana Biotechnology, a NASDAQ-listed biotechnology company focused on engineered cell therapies, will present business updates and an overview at four major healthcare investor conferences in September 2026. Presentations will be webcast and include updates on the company's strategy, operations, and prospects. The company emphasizes its commitment t…